SCYNEXIS, Inc. (SCYX) vs TherapeuticsMD, Inc. (TXMD)
- SCYNEXIS, Inc. SCYX 3.67 −6.14%
- TherapeuticsMD, Inc. TXMD 1.90 −1.55%
SCYNEXIS, Inc. and TherapeuticsMD, Inc. are both Drug Manufacturers Specialty & Generic companies. SCYNEXIS, Inc. is the larger, with a market value of $38.9M against $22.3M — 1.7× the size. SCYNEXIS, Inc. grew revenue faster over the last twelve months: 682.5% against 27.8%. TherapeuticsMD, Inc. has the higher net margin (−6.64% vs −49.7%) and the higher return on invested capital (−13.8% vs −110.7%). Across the 16 metrics below, TherapeuticsMD, Inc. leads on 9 and SCYNEXIS, Inc. on 7.
Valuation
Profitability
| Metric | SCYX | TXMD | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 53.94% |
| Operating margin | (109.90%) | (120.89%) | 0.00% |
| Net margin | (49.74%) | (6.64%) | 0.00% |
| Free cash flow margin | (64.67%) | 94.71% | 0.00% |
| Return on equity | (18.38%) | (0.80%) | (0.40%) |
| Return on assets | (15.09%) | (0.57%) | (3.32%) |
| Return on invested capital | (110.72%) | (13.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack